Dekkers joins Biogen board

Biogen Idec Inc. announced today that Marijn E. Dekkers, chief executive of Thermo Fisher Scientific Inc., has been elected to its board of directors.

Biogen Idec of Cambridge develops, manufactures, and commercializes novel therapies focusing on oncology and immunology; it's known for such drugs as Avonex, a treatment for multiple sclerosis, and Rituxan, which treats non-Hodgkin's lymphoma.

Thermo Fisher Scientific of Waltham manufactures scientific instruments.
(By Chris Reidy, Globe staff)